The US. abandoning NAFTA to conflict in North Korea are real risks, but otherwise the global economic recovery looks good, says Jean-Francois Perrault, chief economist, Scotiabank.
Risks such as North Korea are getting swept aside by the tide of global liquidity, says Jeremy Coller, chairman & CIO, Coller Capital.
UN sanctions on North Korea are unlikely to bring a halt to missile and nuclear tests, but the U.S. will push that path for now, including a complete oil embargo, says Harry Kazianis, director of Defense Studies, Center for the National Interest.
South Korea is actively responding to the weapon tests by the North with its own military buildup, says Scott Seaman, director, Asia, Eurasia Group.
A war on the Korean Peninsula is the "single biggest geopolitical threat" and one that would move markets, says Tina Fordham, managing director and chief global political analyst, Citi.
Douglas Paal of the Carnegie Endowment for International Peace outlines what to expect in response to tensions on the Korean Peninsula and says deployments of bombers will likely be temporary.
Markets in Japan will likely take a new weapons test by North Korea in stride, says Nicholas Smith, Japan strategist, CLSA.
Karsten Junius, chief economist, Bank J Safra Sarasin, says the markets need to be more mindful that the tensions on the Korean peninsula are a major tail risk.
CNBC's Geoff Cutmore says the top concern of IMF and World Bank members is the outcome of the French election, and its impact on the future of the EU.
David Rubenstein, co-founder and co-CEO at The Carlyle Group, reveals what he thinks is the biggest risk for the global economy.
The EPA claims only 9 states in the U.S. report safe lead levels in their water supply, an issue causing serious public health concerns.
The EPA claims 41 states in the U.S. have heightened lead levels in their water supply, impacting millions of lives and costing billions of dollars in damages.
Divisions over how to cope with the flood of migrants is threatening the EU's global standing. Will it diminish its ability to tackle reform?
Slaves today can sell for almost nothing, and indirectly make corporations billions of dollars. Modern-day abolitionists are fighting back.
The atrocity of indentured servitude is the world's fastest-growing crime. Will a new bill passed by Obama signal the world to take notice?
A lawsuit filed by a Florida company against a billion-dollar drug firm strikes at the heart of the nationwide painkiller epidemic.
A former sales manager at Insys Therapeutics pleads guilty to charges of fraud and accepting kickbacks. CNBC's Dina Gusovsky reports.
A former sales rep for Insys Pharmaceuticals, which is under investigation in multiple US states, has pleaded guilty to federal charges of fraud.
America's addiction to painkillers is taking a toll on the workplace. Is enough being done by companies to get it under control?
The financial and socioeconomic costs of prescription painkiller abuse are showing up in the workplace.
This special report looks and whether investors are better served by active or passive investment strategies.
Business icons and provocateurs share their innovative models. Learn how to upend old industries and start new ones that move markets.
Top leaders from business, government and academia come together to address cyberthreats and secure America’s future.